The effect of the modification of ceramide on the carbohydrate antigenicity of gangliosides

Sapporo Medical Journal

Volumn 66, Issue 1-2, 1997, Pages 41-50

  Daino, Takumi ^a   Gasa, Shinsei ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012314340     PISSN: 0036472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 1981, 50 : 733-64.
2. Kannagi R, Nudelman E, Hakomori S. Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci U S A 1982, 79 : 3470-3474.
3. Itonori S, Hidari K, Sanai Y, Taniguchi M, Nagai Y. Involvement of the acyl chain of ceramide in carbohydrate recognition by an antiglycolipid monoclonal antibody : the case of an anti-melanoma antibody, M2590, to GM3-ganglioside. Glycoconj J 1989, 6 : 551-560.
4. Nudelman E, Hakomori S, Kannagi R, Levery S, Yeh MY, Hellstrom KE, Hellstrom I. Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2. J Biol Chem 1982, 257 : 12752-12756.
5. Nakamura H, Arai M, Kawaguchi T, Horikawa K, Hidaka M, Sakamoto K, Iwamori M, Nagai Y, Takatsuki K. Monoclonal antibody to galactosylceramide : discrimination of structural difference in the ceramide moiety. FEBS Lett 1989, 258 : 230-232.
6. Obeid LM, Linardic CM, Karolak LA, Hunnum YA. Programmed cell death induced by ceramide. Science 1993, 259 : 1769-1771.
7. Li Ji, Zhang G. Uemath S, Akahori Y, Hirabayashi Y. Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett 1995, 358 : 211-214.
8. Suetake K, Tsuchihashi K, Inaba K, Chiba M, Ibayashi Y, Hashi K, Gasa S. Novel modification of ceramide : rat glioma ganglioside GM3 having 3-O-acetylated sphingenine. FEBS Lett 1995, 361 : 201-205.
9. Tsuchihashi K, Daino T, Akino T, Gasa S. Synthesis of a glioma-related ganglioside, O-Ac GM3 having 3-O-Ac ceramide and its substrate property toward hydrolases. J Lipid Res 1996, 37 : 2136-2144.
10. Tai T, Cahan LD, Paulson JC, Saxton RE, Irie RF. Human monoclonal antibody against ganglioside GD2 ; use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients. J Natl Cancer Inst 1984, 73 : 627-633.
11. Higashi H, Fukui Y, Ueda S, Kato S, Hirabayashi Y, Matsumoto M, Naiki M. Sensitive enzyme-immunostaining and densitometric determination on thin-layer chromatography of N glycolylneuraminic acid-containing glycosphingolipids, Hanganutziu-Deicher antigens. J Biochem 1984, 95 : 1517-1520.
12. Nores GA, Dohi T, Taniguchi M, Hakomori S. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen : requirements for tumor-associated antigen and immunogen. J Immunol 1987 139 : 3171-3176.
13. Kawashima I, Nakamura O, Tai T. Antibody responses to ganglio series gangliosides in different strains of inbred mice. Mol Immunol 1992, 29 : 625-632.
14. Livingston PO, Ritter G, Calves MJ. Antibody response after immunization with the gangliosides GM1, GM2, GM3. GD2 and GD3 in the mouse. Cancer Immunol Immunother 1989, 29 : 179-184.
15. Ravindranath MH, Morton DL, Irie RF. Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides J Autoimmun 1994, 7 : 803-816.
16. Takahashi K, Ono K, Hirabayashi Y, Taniguchi M Escape mechanism of melanoma from immune system by soluble melanoma antigen. J Immunol 1988, 140 : 3244-3248.
17. Ravindranath MH, Brazeau SM, Morton DL. Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside. Experientia 1994, 50 : 648-653.
18. Ravindranath MH, Morton DL. Role of gangliosides in active immunotherapy with melanoma vaccine, Int Rev Immunol. 1991, 7 : 303-329.